Search results for: 'decor intelligent pharma'

The modern threat landscape has undergone a profound transformation, driven by the global push toward digitalization. This has led to expanded attack surfaces, heightened IT complexity, and increased risks in supply chains. Today, threat actors launch multivector attacks that target organizations internal networks and their external digital assets...

Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...

The global push toward digitalization has expanded attack surfaces and heightened IT risks. Today, threat actors launch multi- vector attacks on organizations, targeting internal networks and external digital assets. As organizations ramp up cybersecurity spending and tools to mitigate these risks, the efficacy of these measures depends on timely i...

In the big data era, the need for artificial intelligence (AI) tools and applications for intelligence uses has increased dramatically as armed forces and intelligence agencies focus on consolidated solutions to collect, process, and analyze data from seemingly endless sources. Miliary intelligence (MILINT) analytics is crucial for battlefield effi...

21 Mar 2025  |  Global  |  Market Research

Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030

The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model

Infographics

×

As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...

OSINT solutions are the foundation of many organizations' intelligence and investigative strategies, enabling them to gather, analyze, and act on publicly available information to mitigate risks, uncover threats, and support decision-making. Despite the rapid digital transformation across industries, OSINT methodologies have remained largely unchan...

This Frost Radar™ analysis benchmarks vendors that offer open-source intelligence (OSINT) platforms for businesses, law enforcement, and government agencies to accomplish threat intelligence, due diligence, and risk evaluation investigations. Frost & Sullivan uses its proprietary benchmarking methodology to plot the top global vendors in the indu...

Computed tomography, X-ray radiography, and magnetic resonance imaging have been invaluable tools in disease diagnosis and treatment efficacy assessments, but the practice of manual viewing and grading medical images to identify abnormalities is time-consuming and can delay diagnosis for critical patients. Intelligent imaging analysis systems that...

The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing chan...